Beacon Biosignals
PrivateLast Round
Series C
Jun 9, 2026
Est. Valuation
$286.85M
Total Funding Raised
$452M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Beacon Biosignals is a healthcare technology company that provides an artificial intelligence-driven EEG analysis and diagnosis platform to accelerate drug development and improve brain health outcomes.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Medical AI, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Hardware Sales, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beacon Biosignals Comparables
Compare Beacon Biosignals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cumulus Neuroscience | 77% | |
| Zeto, Inc. | 77% | |
| Empatica | 76% |
Beacon Biosignals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jun 9, 2026 | ||||
| Series B | Apr 6, 2026 | ||||
| Series B | Nov 13, 2025 | ||||
| Series A | Nov 8, 2021 | ||||
| Seed | May 30, 2019 | ||||
Seed | May 1, 2019 |
Key People
Founding team and executive leadership
Beacon Biosignals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S32 | Series B |
| Kicker Ventures | Series B |
| GV | Series B |
| JSL Health Capital | Series B |
| Nexus NeuroTech Ventures | Series B |
| Innoviva | Series B |
| Catalio Capital Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2026
Grew 38% QoQ, from 121 to 167 employees.
- Jun 9, 2026
$225M round led by General Catalyst and HarbourVest Partners.
Recent news
Latest coverage and updates
- attends_eventJun 22, 2026
Beacon Biosignals, Inc. attended event SLEEP 2026 on Jan 1st '26.
Beacon Biosignals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Beacon Biosignals's valuation, stock price, and market status.
Is Beacon Biosignals a public or private company?
Beacon Biosignals is a private company.
What is the current stock price of Beacon Biosignals?
Beacon Biosignals is a private company with no public stock price. No recent secondary market data is available.
How much is Beacon Biosignals worth (valuation)?
Beacon Biosignals's valuation is estimated at $286.9M based on funding round data.
Can I buy Beacon Biosignals stock?
Beacon Biosignals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Beacon Biosignals's last funding round?
Beacon Biosignals's most recent funding round was Series C on November 13, 2025.
Who are the main investors in Beacon Biosignals?
Key investors in Beacon Biosignals include GV, Innoviva, General Catalyst, HarbourVest Partners.
Will Beacon Biosignals IPO soon?
No public IPO plans have been announced for Beacon Biosignals.
How can I track Beacon Biosignals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Beacon Biosignals's secondary market activity and sign up for updates.